GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Formycon AG (XTER:FYB) » Definitions » Price-to-Tangible-Book

Formycon AG (XTER:FYB) Price-to-Tangible-Book : (As of May. 16, 2024)


View and export this data going back to 2010. Start your Free Trial

What is Formycon AG Price-to-Tangible-Book?

As of today (2024-05-16), Formycon AG's share price is €43.60. Formycon AG's Tangible Book per Share of Dec. 2023 for the quarter that ended in Dec. 2023 was €-3.13. Hence, Formycon AG's Price to Tangible Book Ratio of today is .

The historical rank and industry rank for Formycon AG's Price-to-Tangible-Book or its related term are showing as below:

During the past 13 years, Formycon AG's highest Price to Tangible Book Ratio was 12.05. The lowest was 6.70. And the median was 8.86.

XTER:FYB's Price-to-Tangible-Book is not ranked *
in the Biotechnology industry.
Industry Median: 2.81
* Ranked among companies with meaningful Price-to-Tangible-Book only.

A closely related ratio is called PB Ratio. As of today, Formycon AG's share price is €43.60. Formycon AG's Book Value per Sharefor the quarter that ended in Dec. 2023 was €31.32. Hence, Formycon AG's P/B Ratio of today is 1.39.


Formycon AG Price-to-Tangible-Book Historical Data

The historical data trend for Formycon AG's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Formycon AG Price-to-Tangible-Book Chart

Formycon AG Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Tangible-Book
Get a 7-Day Free Trial Premium Member Only Premium Member Only 6.70 8.63 11.33 - -

Formycon AG Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Price-to-Tangible-Book Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 11.33 2.91 - - -

Competitive Comparison of Formycon AG's Price-to-Tangible-Book

For the Biotechnology subindustry, Formycon AG's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Formycon AG's Price-to-Tangible-Book Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Formycon AG's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where Formycon AG's Price-to-Tangible-Book falls into.



Formycon AG Price-to-Tangible-Book Calculation

Formycon AG's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book=Share Price/Tangible Book per Share (Q: Dec. 2023 )
=43.60/-3.126
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.


Formycon AG Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of Formycon AG's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.


Formycon AG (XTER:FYB) Business Description

Traded in Other Exchanges
Address
Fraunhoferstrasse 15, Martinsried, Planegg, BY, DEU, 82152
Formycon AG is a pharmaceutical company. It is engaged in the development of pharmaceutical and biopharmaceutical products and the development of drug delivery systems. Its focus is on treatments in ophthalmology and immunology as well as other chronic diseases. The company's pipeline in the biosimilar drugs category includes FYB201, FYB202, FYB203, and FYB207 for the treatment of COVID 19. It is also engaged in the provision of diagnostic laboratory services and works for third parties and the carrying out of diagnostic laboratory services.
Executives
Dr. Stefan Glombitza Board of Directors
Dr. Carsten Brockmeyer Board of Directors
Dr. Nicolas Combé Board of Directors

Formycon AG (XTER:FYB) Headlines

No Headlines